Newborns in the United States are routinely tested for certain conditions including metabolic and other disorders, and with advances in whole-genome sequencing, researchers and others wonder whether that approach will soon be incorporated into newborn screening programs to detect an even greater range of diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Sequencing Future

Peace of Mind

To Tell?

Consent and Research

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.